Finance

Lists
Why is BNTC down 4,57%?
Dive Deeper
BNTC:NASDAQ
Benitec Biopharma Inc
8,15 $
-4,57%
(-0,39) 1D
8,15 $
0,00% (0,00)
After hours
Closed: 17 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTC...
Open
8,58 $
High
8,63 $
Low
8,00 $
Mkt. cap
294,37 մլն
Avg. vol.
186,69 հզր
Volume
175,45 հզր
52-wk high
14,39 $
52-wk low
8,00 $
EPS
-1,02 $
Beta
0,26
Shares outstanding
36,12 մլն
No. of employees
24
Open
8,58 $
High
8,63 $
Low
8,00 $
Mkt. cap
294,37 մլն
Avg. vol.
186,69 հզր
Volume
175,45 հզր
52-wk high
14,39 $
52-wk low
8,00 $
EPS
-1,02 $
Beta
0,26
Shares outstanding
36,12 մլն
No. of employees
24
News stories
From web sources and news partners
About Benitec Biopharma Inc
CEO-
Employees24
Founded-
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to BNTC in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for BNTC in the last 3 months.
Highest
Current 8,15 $
32,00 $ (+292,64%)
Average
21,85 $ (+168,10%)
Lowest
14,00 $ (+71,78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mani Foroohar
Leerink Partners
Buy
Reiterated
18,27 $
+124,2%
11/17/2026
Yun Zhong
Wedbush
Buy
Reiterated
20,00 $
+145,4%
11/17/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
32,00 $
+292,6%
11/02/2026
Tiago Fauth
Raymond James
Buy
Initiated
14,00 $
+71,8%
10/23/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
09/15/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
25,00 $
+206,7%
09/15/2026
Debjit Chattopadhyay
Guggenheim
Hold
Downgraded
-
-
06/10/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
18,00 $
+120,9%
05/15/2026
Silvan Tuerkcan
Citizens JMP
Buy
Maintained
22,00 $
+169,9%
11/04/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,83 մլն
6,30 մլն
7,89 մլն
8,62 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,54 մլն
7,28 մլն
6,54 մլն
5,86 մլն
Operating expense
13,38 մլն
13,58 մլն
14,43 մլն
14,48 մլն
Total operating expenses
13,38 մլն
13,58 մլն
14,43 մլն
14,48 մլն
Operating income
-13,38 մլն
-13,58 մլն
-14,43 մլն
-14,48 մլն
Other non operating income
19,00 հզր
-17,00 հզր
39,00 հզր
-1,00 հզր
EBT including unusual items
-11,84 մլն
-11,94 մլն
-12,81 մլն
-12,92 մլն
EBT excluding unusual items
-11,84 մլն
-11,94 մլն
-12,81 մլն
-12,92 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,84 մլն
-11,94 մլն
-12,81 մլն
-12,92 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1,39 մլն
1,59 մլն
1,57 մլն
1,58 մլն
Interest expense
-
-
-
-
Net interest expenses
1,39 մլն
1,59 մլն
1,57 մլն
1,58 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,36 մլն
-13,57 մլն
-14,41 մլն
-14,46 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps